Chenhao Xu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
AFP/PIVKA-II double-positive status indicates a high-risk subtype of hepatocellular carcinoma in liver transplantation: retrospective cohort study and phosphoproteome evaluation.
Journal: International journal of surgery (London, England)
Published: August 28, 2025
Glucokinase Regulatory Protein (GCKR) Links Metabolic Reprogramming With Immune Exclusion: Insights From a Pan-Cancer Analysis and Gastric Cancer Validation.
Journal: Human mutation
Published: August 09, 2025
Lean Metabolic Dysfunction-Associated Steatotic Liver Disease: A Wolf in Sheep's Clothing.
Journal: Cell biochemistry and function
Published: April 16, 2025
Integrating spatial transcriptomics and single-cell RNA-seq dissects immune microenvironment in fatty liver regeneration.
Journal: Clinical and translational medicine
Published: March 28, 2025
Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis.
Journal: Cancer letters
Published: January 23, 2025
Impact of Donor CMV-Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
Journal: Journal of medical virology
Published: August 19, 2024
Genetic engineering drives the breakthrough of pig models in liver disease research.
Journal: Liver research (Beijing, China)
Published: May 02, 2024
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
Journal: European journal of medical research
Published: April 20, 2024
Heterogeneity of hepatocellular carcinoma that responds differently to combination therapy with TACE and Sorafenib as determined by digital spatial gene expression profiling.
Journal: Genes & genomics
Published: April 14, 2024
Last Updated: 09/26/2026